Pericardial Mesothelioma Resources and Research Information

Precisely what is pericardial mesothelioma?

This mesothelioma is a dangerous heart condition which comes from cancerous cells accumulating on the lining of the heart. Comparable to pleura and peritoneal mesothelioma, this is a deadly health problem due to the significance of the area on which it develops.

So what leads to the mesothelioma and who are most vulnerable?

The main cause of pericardial mesothelioma is contact to asbestos particles and fibres.For this reason those at risk are those particular who are most probably to have inhaled these life-threatening fibres such as building workers and asbestos manufacturers. People who are in contact with these people also have a risk of getting this type of mesothelioma due to the reason that this group of people may have asbestos fibres stuck to their clothing or hair.

What exactly are the indications of pericardial mesothelioma?

The indications of the mesothelioma may vary from individual to individual. Usual warning signs and symptoms include continuous coughing, coughing up blood, shortness of breath, chest pain and heart rhythm disorder. Other symptoms affected individuals may encounter are nausea, losing weight, throwing up and loss of the appetite.

Now what are the treatment options existing for pericardial mesothelioma?

There are a range of individual treatment options for pericardial mesothelioma however none of them have a high level of success. Chemo therapy, radiation therapy, dual therapy and surgery are the treatment methods made available. Chemo therapy also includes using drugs to destroy cancerous cells and radiation therapy makes use dosages of radiation to destroy cancer cells despite the fact this is very challenging in the instance of pericardial mesothelioma due to the surrounding important and vital organs which include the heart and lungs. Dual therapy is a treatment procedure joining radiation therapy with chemo therapy. Surgery comes in two shapes; aggressive surgery and palliative surgeries.

Aggressive surgery is a extremely challenging course of treatment and involves removing large pieces of cancerous cells in an attempt to win long term control over the cancer. Palliative procedures simply strives to minimize the symptoms for the patient.

Just how much exposure to asbestos is needed for there to be a risk of getting the mesothelioma?

This depends on how robust and resistant the individual is to disease and on the amount of asbestos in the environment around him. It is possible to get the mesothelioma from as little as a few of months of exposure to asbestos in spite of the fact that on average it would take a couple of years for sufficient asbestos fibres to build up to cause cancer.

What is the diagnosis for pericardial mesothelioma?

This is greatly dependent on how early and how dramatically the cancer is treated. If pericardial mesothelioma is treated when it has completely formed and matured then the odds of a patient's survival is minimal. The prognosis could be just a couple of months.

Is there any kind of encouraging research into curing mesothelioma?

Research into cures of pericardial mesothelioma and every other type of mesothelioma is being done in several research labs all over the USA. Many pharmaceutical corporations and organizations are also working intensely to research new drugs for chemotherapy. So far, research has |for the most part been unsuccessful.

*** Find Mesothelioma Information ***
Lawyers Video Presentations & Specialized Lawyers
http://wwwinvestigator.com/

Lung Cancer Clinical Trials: Research Studies to Bring Better and Safer Treatments

Many lung cancer clinical trials are sponsored by government agencies, private pharmaceutical organizations and health care institutes worldwide. In USA, the specific agencies and institutes involved in clinical trial sponsorship are the Department of Defense (DOD), National Institute of Health (NIH), and Department of Veterans Affairs (VA). Today, some organizations are devoted to recruiting volunteer participants to these experimental studies. With enough info guide and explanation, patients are now more aware, knowledgeable and willing to participate in clinical trials.

These clinical trials are being researched to develop new treatments for Lung Cancer. The medical studies give access to cutting-edge treatments at no cost to the participants. There are more than 200 clinical trials being conducted including a Cancer, Three Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer and A Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patient's with Completely Resected Stage IB (>4 cm) - IIIA Non Small Lung Cancer.

Among the various revolutionary clinical trials being held, let us highlight the collaborative advanced stage tissue lung cancer (Castle) study at the Addario Lung Cancer Medical Institute at San Carlos, California. The objective is to conduct research and laboratory tests on cancer tissue and blood samples by cancer victims. After collection, these samples and clinical information will be stored at the ALCMI Biorepository and Data Repository.

Around 250 advanced stage lung cancer participants from the United States and some from Europe are targeted. They are those in Stage M1A and M1B Non-Small Cell Lung Cancer (NSCLC) and all stages of small cell lung cancer (SCLC). If you are qualified and accepted, you will be asked to provide your medical profile, tumor tissue and blood samples.

As a preliminary entry requirement, your study physician will submit your tissue to a testing laboratory. Once the test reports come in, the results are indicated in your health file records as a guide for your doctor to plan your care and treatment. When there are changes in your treatment, new blood samples and latest medical information will be requested from you and there will be communication between you and your doctor every three months for an update on your health status. Whatever research reports collected about you will not be imputed in your research records.

The other featured clinical trial is the Radiation Therapy in treating patients with extensive small cell lung cancer being held at Sparta, New Jersey. The primary objective of this research is to make a comparative 1-year overall median survival rate between patients with extensive stage small cell lung cancer who are treated with prophylactic cranial irradiation and those who are treated with platinum based chemotherapy but without a consolidative extracranial radiation therapy. Its secondary goals are to compare adverse effects of the treatments in the patients, evaluate patterns of failure, compare the time to first failure and evaluate the percentage of radiotherapy dosage.

To be eligible, you must be diagnosed within the past 6 months of extensive stage SCLC and must have 1-3 extracranial metastatic lesions. Another criterion is you must have completed 4-6 courses of platinum-based-chemotherapy within the past 8 weeks and have partial or complete response to chemotherapy. You must also have no progression and no limited stage SCLC even if the illness has progressed and no brain or CNS metastases.

Their criteria for other characteristics for females are not pregnant or nursing, negative pregnancy test and must use contraceptives during fertility stage. Participant must have no severe, active co-morbidity such as acute bacterial or fungal infection requiring lV antibiotics and chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization. You must also pass the required zubrod performance, ANC, platelets, hemoglobin, Serum ALT and AST, Serum Bilirubin and Serum Creatinine.

After your participation in these lung cancer clinical trials study is completed, you will be provided with appropriate follow-up care and assistance. To start with, you need to pass the prerequisite entry and once accepted, you will be a part of history in the making in advancing medical research for Lung Cancer for better and safer treatments in the future!

My name is Jet Jones and I research and write about alternative cancer cures. Please visit my site at http://lungcancer-stages.com/ to find information about lung cancer stages and treatments that can help you better understand this dreaded disease.